Suppr超能文献

SCEDOSPORIUM INFECTION IN A PATIENT WITH ANTI-TNFα THERAPY.

作者信息

Nguyen Caroline T, Raychaudhuri Siba P

机构信息

Department of Medicine, VA Medical Center Sacramento and UC Davis School of Medicine, Division of Rheumatology, Allergy and Clinical Immunology , Hospital Way, Mather, CA 95655, USA.

出版信息

Indian J Dermatol. 2011 Jan;56(1):82-3. doi: 10.4103/0019-5154.77560.

Abstract

Patients on anti-TNFα therapy are at increased risk for rare opportunistic infections. Here we are reporting a case of Scedosporium apiospermum infection in a patient treated with anti-TNF for 5 years. Patients on anti-TNFα need close follow-up and clinicians should be suspicious for atypical infections in these immunocompromised hosts.

摘要

相似文献

1
SCEDOSPORIUM INFECTION IN A PATIENT WITH ANTI-TNFα THERAPY.
Indian J Dermatol. 2011 Jan;56(1):82-3. doi: 10.4103/0019-5154.77560.
3
Pulmonary Scedosporium apiospermum Infection with Pulmonary Tumorlet in an Immunocompetent Patient.
Intern Med. 2018 Dec 1;57(23):3485-3490. doi: 10.2169/internalmedicine.1239-18. Epub 2018 Aug 10.
4
Management of pulmonary infection by thoracoscopic surgery in an immunocompetent woman.
J Int Med Res. 2020 Jul;48(7):300060520931620. doi: 10.1177/0300060520931620.
7
Scedosporium apiospermum fungemia in a lung transplant recipient.
Chest. 2002 May;121(5):1714-6. doi: 10.1378/chest.121.5.1714.
8
[Scedosporium apiospermum disseminated infection in a single lung transplant recipient].
Rev Iberoam Micol. 2011 Jul-Sep;28(3):139-42. doi: 10.1016/j.riam.2011.06.007.
9
Cutaneous hyalohyphomycosis by Scedosporium apiospermum in an immunocompromised patient.
Mycoses. 2011 May;54(3):259-61. doi: 10.1111/j.1439-0507.2009.01797.x.
10
Nebulized voriconazole in infections with Scedosporium apiospermum--case report and review of the literature.
J Cyst Fibros. 2014 Jul;13(4):400-2. doi: 10.1016/j.jcf.2013.10.014. Epub 2013 Nov 18.

引用本文的文献

1
Scedosporiosis and lomentosporiosis: modern perspectives on these difficult-to-treat rare mold infections.
Clin Microbiol Rev. 2024 Jun 13;37(2):e0000423. doi: 10.1128/cmr.00004-23. Epub 2024 Mar 29.
2
Fungal infection risks associated with the use of cytokine antagonists and immune checkpoint inhibitors.
Exp Biol Med (Maywood). 2020 Jul;245(13):1104-1114. doi: 10.1177/1535370220939862. Epub 2020 Jul 8.
3
Authors' reply.
Indian J Dermatol. 2013 Jan;58(1):81.

本文引用的文献

1
Incidence and nature of infectious disease in patients treated with anti-TNF agents.
Autoimmun Rev. 2009 Dec;9(2):67-81. doi: 10.1016/j.autrev.2009.08.006. Epub 2009 Aug 27.
4
Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients.
Antimicrob Agents Chemother. 2008 May;52(5):1743-50. doi: 10.1128/AAC.01388-07. Epub 2008 Jan 22.
5
Infections caused by Scedosporium spp.
Clin Microbiol Rev. 2008 Jan;21(1):157-97. doi: 10.1128/CMR.00039-07.
7
Chronic pulmonary scedosporiosis simulating aspergillosis.
Respirology. 2005 Nov;10(5):682-4. doi: 10.1111/j.1440-1843.2005.00769.x.
8
Histoplasmosis after treatment with anti-tumor necrosis factor-alpha therapy.
Am J Respir Crit Care Med. 2003 May 1;167(9):1279-82. doi: 10.1164/rccm.200206-563OC. Epub 2003 Feb 13.
9
Scedosporium apiospermum fungemia in a lung transplant recipient.
Chest. 2002 May;121(5):1714-6. doi: 10.1378/chest.121.5.1714.
10
In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi.
J Antimicrob Chemother. 1998 Dec;42(6):741-5. doi: 10.1093/jac/42.6.741.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验